Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital Rubella syndrome elimination, the Americas 2001-2008

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 2, 2011, Pages

  Castillo Solórzano, Carlos ^a   Reef, Susan E ^b   Morice, Ana ^c   Vascones, Nancy ^d   Chevez, Ana Elena ^e   Castalia Soares, Rosa ^f   Torres, Carlos ^g   Vizzotti, Carla ^h   Ruiz Matus, Cuauhtémoc ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c Ministry of Health   (Costa Rica)

^d Ministry of Health   (Ecuador)

^e Fundac Xão Nacional de Saúde ^*  (Brazil)

^f Former National Immunization Program   (Brazil)

^g EPI Manager   (Paraguay)

^h EPI Manager   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; RUBELLA VACCINE; RUBELLA ANTIBODY;

ANTIBODY BLOOD LEVEL; ARGENTINA; ARTICLE; BRAZIL; CONGENITAL RUBELLA SYNDROME; COSTA RICA; DRUG SAFETY; ECUADOR; EL SALVADOR; FEMALE; FOLLOW UP; HUMAN; IMMUNE STATUS; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION CONTROL; INFECTION SENSITIVITY; LIVE BIRTH; MASS IMMUNIZATION; NEWBORN ASSESSMENT; PARAGUAY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RUBELLA; TREATMENT CONTRAINDICATION; BLOOD SAMPLING; INFECTION RISK; LOW BIRTH WEIGHT; NEWBORN; PREMATURITY; PRENATAL DRUG EXPOSURE; RUBELLA VACCINATION; TERATOGENICITY;

COMMUNICABLE DISEASE CONTROL; COSTA RICA; FEMALE; FETUS; HUMANS; IMMUNOGLOBULIN M; MASS VACCINATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RISK FACTORS; RUBELLA; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE; SOUTH AMERICA; VACCINES, ATTENUATED;

EID: 80053429316     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir489     Document Type: Article

References (15)

1. Plotkin SA, Reef SE. Rubella vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Philadelphia, PA: Saunders, 2008: 735-71.
2. World Health Organization. WHO expert committee on biological standardization 43rd report. In: W. H. Organization, ed. Technical report series. Geneva: World Health Organization, 1994: 137-201.
3. Vaheri A, Vesikari T, Oker-Blom N, et al. Transmission of attenuated rubella vaccines to the human fetus: a preliminary report. Am J Dis Child 1969; 118:243-6.
4. Recommendation of the Public Health Service Advisory Committee on Immunization Practices. Am J Dis Child 1969; 118:397-9.
5. Tookey PA, Jones G, Miller BH, Peckham CS. Rubella vaccination in pregnancy. CDR (Lond Engl Rev) 1991; 1:R86-8.
6. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-48.
7. Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M de Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis 2003; 187(Suppl 1):S146-52.
8. Pan American Health Organization. Conclusions and recommendations of the XIII Technical Advisory Group meeting on vaccinepreventable diseases (TAG) of the Pan American Health Organization. Quebec: Pan American Health Organization, 1999; 6-7.
9. Badilla X, Morice A, Avila-Aguero ML, et al. Fetal risk associated with rubella vaccination during pregnancy. Pediatr Infect Dis J 2007; 26:830-5. (Pubitemid 47329856)
10. World Health Organization. Rubella and congenital rubella syndrome. WHO-recommended standards for surveillance of selected vaccinepreventable diseases. Geneva, Switzerland: World Health Organization, 2003: 35-9.
11. Hamkar R, Jalilvand S, Abdolbaghi MH, et al. Inadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccine. Vaccine 2006; 24:3558-63.
12. Sato HK, Sao Paulo Study Group for Effects of Rubella Vaccination During Pregnancy. Inadvertent rubella vaccination of pregnant women: the São Paulo experience, 2001. J Infect Dis 2011; 204(Suppl 2): S737-44.
13. Pan American Health Organization. FLASOG to participate in the implementation of strategies to control rubella and Prevent CRS in the Americas. EPI Newsl 2001; 23:6.
14. Bar-Oz B, Levichek Z, Moretti ME, Mah C, Andreou S, Koren G. Pregnancy outcome following rubella vaccination: a prospective controlled study. Am J Med Genet A 2004; 130A:52-4. (Pubitemid 39121561)
15. Castalia Soares R, Siqueira MM, Toscano CM, et al. Follow-up study of unknowingly pregnant women vaccinated against rubella in Brazil, 2001-2002. J Infect Dis 2011; 204(Suppl 2):S729-36.